Frailty and Its Progression With Cardiovascular Disease Risk With Cardiovascular-Kidney-Metabolic Syndrome Stages 1 to 3

Frailty progression and sustained nonrobust state increased CVD risk in CKM stages 1 to 3, while frailty improvement had no significant effect. Our findings highlight frailty as a key CVD risk factor, emphasizing the need for early identification and intervention.